NVRO - Nevro Corp.
| Previous Close | 63.59 |
| Open | 63.95 |
| Bid | 62.02 x 800 |
| Ask | 62.26 x 1000 |
| Day's Range | 61.87 - 63.81 |
| 52 Week Range | 34.75 - 68.94 |
| Volume | 139,289 |
| Avg. Volume | 450,996 |
| Market Cap | 1.904B |
| Beta (3Y Monthly) | 1.07 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.50 |
| Earnings Date | Aug 8, 2019 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 62.56 |
- PR Newswire•2 days ago
Nevro to Report Second Quarter 2019 Financial Results
Company to Host Conference Call on Thursday, August 8, 2019 at 1:30 p.m. PT / 4:30 p.m. ET REDWOOD CITY, Calif. , July 15, 2019 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company ...
- Zacks•15 days ago
Here's Why You Should Hold on to Nevro (NVRO) Stock Now
Nevro (NVRO) is gaining traction from a fortified international footprint and solid prospects in the SCS market. However, severe rivalry is a lingering woe.
- PR Newswire•22 days ago
Nevro Announces Executive Appointments
Names Niamh Pellegrini as Chief Commercial Officer and Lori Ciano as Chief Human Resources Officer REDWOOD CITY, Calif. , June 25, 2019 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device ...
- Simply Wall St.•26 days ago
Nevro Corp. (NYSE:NVRO) Insiders Increased Their Holdings
It is not uncommon to see companies perform well in the years after insiders buy shares. Unfortunately, there are also...
- Zacks•last month
Should You Invest in the SPDR S&P Health Care Equipment ETF (XHE)?
Sector ETF report for XHE
- Insider Monkey•last month
Is Nevro Corp (NVRO) A Good Stock To Buy ?
Amid an overall bull market, many stocks that smart money investors were collectively bullish on surged during the first quarter. Among them, Facebook and Microsoft ranked among the top 3 picks and these stocks gained 40% and 25% respectively. Our research shows that most of the stocks that smart money likes historically generate strong risk-adjusted […]
- Thomson Reuters StreetEvents•last month
Edited Transcript of NVRO earnings conference call or presentation 9-May-19 8:30pm GMT
Q1 2019 Nevro Corp Earnings Call
- PR Newswire•last month
Nevro to Present at BMO 2019 Prescriptions for Success Healthcare Conference
REDWOOD CITY, Calif. , June 11, 2019 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, ...
- Markit•last month
See what the IHS Markit Score report has to say about Nevro Corp.
Nevro Corp NYSE:NVROView full report here! Summary * Bearish sentiment is moderate * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | NeutralShort interest is moderate for NVRO with between 5 and 10% of shares outstanding currently on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | NeutralETF activity is neutral. ETFs that hold NVRO had net inflows of $754 million over the last one-month. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
- Zacks•last month
Nevro (NVRO) Down 3.6% Since Last Earnings Report: Can It Rebound?
Nevro (NVRO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- PR Newswire•2 months ago
Nevro to Highlight Substantial Body of Clinical Evidence Supporting Expanded Applications and Unique Capabilities of HF10 Therapy at the 14th International Neuromodulation Society World Congress
SYDNEY , May 26, 2019 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced ...
- PR Newswire•2 months ago
Nevro Names D. Keith Grossman Chairman of the Board; Michael DeMane as Lead Director
REDWOOD CITY, Calif. , May 20, 2019 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today ...
- Zacks•2 months ago
Nevro (NVRO) Q1 Loss Wider Than Expected, Revenues Down Y/Y
Nevro's (NVRO) domestic and international revenues fall year over year in Q1.
- Investor's Business Daily•2 months ago
This Medtech's Results Could Be Chilling For Giants Abbott, Medtronic
Nevro stock tumbled Friday after the medical technology company's spinal cord stimulator sales lagged the Street's expectations. Now, an analyst says the entire market could be challenged.
Motley Fool•2 months agoNevro Corp (NVRO) Q1 2019 Earnings Call Transcript
NVRO earnings call for the period ending March 31, 2019.
- Zacks•2 months ago
Nevro (NVRO) Reports Q1 Loss, Misses Revenue Estimates
Nevro (NVRO) delivered earnings and revenue surprises of -119.70% and -6.09%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
- Associated Press•2 months ago
Nevro: 1Q Earnings Snapshot
On a per-share basis, the Redwood City, California-based company said it had a loss of $1.45. The results fell short of Wall Street expectations. The average estimate of seven analysts surveyed by Zacks ...
- PR Newswire•2 months ago
Nevro Reports First Quarter 2019 Financial Results
REDWOOD CITY, Calif. , May 9, 2019 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today ...
- Simply Wall St.•2 months ago
Is There An Opportunity With Nevro Corp.'s (NYSE:NVRO) 29% Undervaluation?
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Today we will run through one way of estimating the intrinsic value of Nevro Corp. (NYSE:NVRO) b...
- Insider Monkey•2 months ago
Did Hedge Funds Drop The Ball On Nevro Corp (NVRO) ?
World-class money managers like Ken Griffin and Barry Rosenstein only invest their wealthy clients' money after undertaking a rigorous examination of any potential stock. They are particularly successful in this regard when it comes to small-cap stocks, which their peerless research gives them a big information advantage on when it comes to judging their worth. […]
- Zacks•2 months ago
Analysts Estimate Nevro (NVRO) to Report a Decline in Earnings: What to Look Out for
Nevro (NVRO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- PR Newswire•3 months ago
Nevro to Present at the Bank of America Merrill Lynch Healthcare Conference 2019
REDWOOD CITY, Calif. , April 30, 2019 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, ...
